LTRN 10-Q: SEC filing
Lantern Pharma Inc.
Filed with the SEC on · accession 0001493152-26-052848
LTRN filed a 10-Q (quarterly report) with the SEC on Nov 17, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
Lantern Pharma Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including private placements and warrant issuances.
Key details
✦ Ask GOAX AI about this filing — what it means for LTRN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LTRN?
Click hereFrequently asked questions
What did LTRN file with the SEC on Nov 17, 2026?
LTRN filed a 10-Q (SEC filing). Lantern Pharma Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including private placements and warrant issuances.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other LTRN SEC filings
- SCHEDULE 13G · SEC filingNov 16, 2026
- DEF 14A · Board changeOct 19, 2026
- SCHEDULE 13G/A · SEC filingOct 13, 2026
- 8-K · Delisting noticeOct 1, 2026
- 424B5 · Secondary offeringSep 30, 2026
- 8-K · Secondary offeringSep 30, 2026
- 8-K · SEC filingSep 24, 2026
- 8-K · SEC filingSep 23, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
Get alerts when LTRN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days